梁疆莉,姬秋彦,罗娜,姬光,高娜,马艳,史荔,孙明波,衡燮
LIANG Jiangli,JI Qiuyan,LUO Na,JI Guang,GAO Na,MA Yan,SHI Li,SUN Mingbo,HENG Xie

• 1:中国医学科学院&北京协和医学院医学生物学研究所

摘要(Abstract)：

目的:改进无细胞百日咳疫苗生产用培养基并优化培养条件。方法:用不同浓度溶血(0. 1%)赫氏琼脂及酸水解酪蛋白制备百日咳活性炭培养基,选择最优培养条件;使用百日咳活性炭培养基成功复苏菌种后,优化传代代次和培养时间,评价百日咳活性炭培养基替代羊血包姜氏培养基的可行性;用酸水解酪蛋白代替自制50%酸水解酪蛋白制备改良SS液体培养基,并用ELISA、SDS-PAGE电泳和CHO细胞簇集等方法评价对菌种的培养效果。结果:溶血(0. 1%)赫氏琼脂的加入量为33. 2g/L、酸水解酪蛋白加入量为8g/L时,菌苔生长最快;百日咳活性炭培养基培养第1代72 h、第2代48 h、第3代48 h、第4代24 h和第1代72 h、第2代36 h、第3代24 h的血凝(HA)和UV600均较高,这两组细菌生长状态较好;酸水解酪蛋白制备的百日咳活性炭培养基在优化条件后复苏菌种生长良好,和羊血包姜氏培养基没有明显差异; 8g/L酸水解酪蛋白制备的改良SS液体培养基所得菌量优于50%酸水解酪蛋白制备培养基(P=0. 001),改良SS液体培养基培养所得百日咳毒素纯度、产量和CHO细胞簇集活性均较好。结论:使用酸水解酪蛋白的百日咳活性炭培养基和改良SS液体培养基所得的百日咳杆菌纯度、产量、活性均较高,适用于无细胞百日咳组分疫苗的生产。
Objective: To improve the culture medium for acellular pertussis vaccine production and optimize its culture conditions. Methods: Hottinger's Agar of different concentrations and acid hydrolyzed casein were used to prepare pertussis activated carbon medium with optimal culture conditions.After resuscitating the strains with pertussis activated carbon medium,passage and culture time were optimized and the feasibility of replacing pertussis activated carbon medium with sheep blood-stained medium was evaluated. Acid hydrolyzed casein was used to replace 50% acid hydrolyzed casein in modified SS liquid medium,and the culture effects of the strain were evaluated by ELISA,SDS-PAGE electrophoresis and CHO cell clustering. Results: When Hottinger's Agar was added in an amount of33. 2 g/L and acid hydrolyzed casein was added in an amount of 8 g/L,the lawn grew with the fastest speed. HA and UV600 of pertussis activated carbon medium were higher and bacteria grew better in two sub-cultures-the first generation 72 h,the second generation 48 h,the third generation 48 h,and the fourth generation 24 h and the first generation 72 h,the second generation 36 h,and the third generation 24 h. The pertussis activated carbon medium prepared by acid hydrolysis of casein was well-developed after optimized conditions,and there was no significant difference between the blood and the culture medium of sheep blood. The number of bacteria in the modified SS liquid medium prepared by8 g/L acid hydrolysis casein was better than that of self-made 50% acid hydrolysis casein preparation medium(P = 0. 001),and the purity,yield and bioactivity to CHO cells were good. Conclusion: The pertussis dried bacteria obtained by the pertussis activated carbon medium using acid hydrolyzed casein and the modified SS liquid medium have higher purity,yield and activity,and were suitable for the production of the acellular pertussis vaccine.

关键词(KeyWords)： 博德特菌,百日咳;百日咳毒素;培养基;仓鼠卵巢细胞;酶联免疫吸附测定
Bordetella pertussis;pertussis toxin;culture medium;CHO cells;enzyme-linked immunosorbent assay

Abstract:

Keywords:

基金项目(Foundation): 国家科技重大专项课题基金资助项目(2015ZX09101031);; 中国医学科学院重大协同创新资助项目“创新性疫苗研究”(2016-12M-1-019)

作者(Author): 梁疆莉,姬秋彦,罗娜,姬光,高娜,马艳,史荔,孙明波,衡燮
LIANG Jiangli,JI Qiuyan,LUO Na,JI Guang,GAO Na,MA Yan,SHI Li,SUN Mingbo,HENG Xie

DOI: 10.19367/j.cnki.1000-2707.2018.10.021

参考文献(References)：

• [1]KHT Y,DUCLOS P,EAS N,et al. An update of the global burden of pertussis in children younger than 5years:a modelling study[J]. Lancet Infectious Diseases,2017,17(9):974.
• [2]DORJI D,MOOI F,YANTORNO O,et al. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance[J].Medical Microbiology&Immunology,2018,207(2):1-24.
• [3]CHEN P Y,JENG-MIN C,YANG Y F,et al. Heterogeneous aging effects on functional connectivity in different cortical regions:A resting-state functional MRI study using functional data analysis[J]. Plos One,2016,11(9):e0162028.
• [4]PRYMULA R,KIENINGER D,FEROLDI E,et al. Immunogenicity and safety of primary and booster vaccinations of a fully liquid DTa P-IPV-HB-PRP-T hexavalent vaccine in healthy infants and toddlers in Germany and the Czech republic[J]. The Pediatric Infectious Disease Journal,2018,37(8):823-830.
• [5]HANSEN J,TIMBOL J,LEWIS N,et al. Safety of DTa P-IPV/Hib vaccine administered routinely to infants and toddlers[J]. Vaccine,2016,34(35):4172-4179.
• [6]REYNOLDS D L,VIDOR E. Fully liquid DTa P-IPV-Hib pediatric combination vaccine(Pediacel):a review of 18years of clinical experience[J]. Expert Review of Vaccines,2014,13(8):943.
• [7]STAINER D W,SCHOLTE M J. A simple chemically defined medium for the production of phase I Bordetellu pertussis[J]. General Microbiology,1971,63:211-220.
• [8]ANDORN N,KAUFMAN J B,CLEM T R,et al,Largescale growth of bordetella pertussis for production of extracellular toxin[J]. New York Academy of Sciences,1990,589(1):363.
• [9]IMAIZUMI A,SUZUKI Y,ONO S,et al. Effect of heptakis(2,6-O-dimethyl)beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis[J]. Infect Immun,1983,41(3):1138-1143.
• [10]国家药典委员会.中华人民共和国药典(3部)[M].北京:中国医药科技出版社,2015.
• [11]徐颖华,卫辰,王丽婵,等. CHO细胞簇集试验在无细胞百日咳疫苗质量控制中的应用[J].中国生物制品学,2014,27(10):1279-1282.
• [12]赵铠,章以浩.医学生物制品学[M].北京:人们卫生出版社,2007.
• [13]BUASRI W,IMPOOLSUP A,BOONCHIRD C,et al. Construction of bordetella pertussis strains with enhanced production of geneti-cally-inactivated pertussis toxin and pertactin by unmarked allelic exchange[J]. BMC Microbiol,2012,12(1):61-76.
• [14]KATADA T,UI M. Islet-activating protein,a modifier of receptor-mediated regulation of rat isletadenylate cyclase[J]. J Biol Chem,1981,256(16):8310-8317.
• [15]SHAHIN R D,BRENNAN M J,LI Z M,et al. Characterization of the protective capacity and immunogenicity of the 69-kd outer membrane protein of bordetella pertussis[J]. Experimental Medicine,1990,171(1):63-73.
• [16]ALAN KIMURA,KENNETH T,MOUNTZOUROS,et al.Bordetella pertussis filamentous hemagglutinin:Evaluation as a protective antigen and colonization factor in a mouse respiratory infection model[J]. Infection And Immunity,1990,58(1):7-16.

文章评论(Comment)：